Researchers at the Princess Margaret Cancer Centre (PM) are invited to submit applications for a Tier 2 Canada Research Chair (CRC) in Cancer Research. Applicants must hold a Scientist or Senior Scientist appointment at PM. Applicants can also be Clinician Scientists with designated wet laboratory space who have been appointed by the PM Research Director.

 

In order to address the underrepresentation of groups who experience systemic barriers in the CRC Program (as identified by the Tri-Agency Institutional Programs Secretariat), this special call is open only to individuals who self-identify as members of one or more of the four federally designated groups (women, racialized minorities/persons of colour, persons with a disability, or Indigenous Peoples) as defined by the Employment Equity Act or who identify as transgender, gender-fluid, nonbinary or Two-Spirit. This initiative follows the provisions for special programs as described by the Ontario Human Rights Commission. The identification of outstanding candidates from these designated group supports the University of Toronto and University Health Network (UHN) commitments to equity, diversity, and inclusion, and our public mission for the pursuit of excellence and equity, as well as the institutional capacity to fulfill the objectives of the University’s Canada Research Chairs Equity, Diversity and Inclusion Action Plan. 

 

Tier 2 chairs are for emerging scholars, and the successful nominee should be within ten years of receiving their PhD [or Highest Degree]. To meet the criteria of the program, nominees must be excellent emerging world-class researchers who have demonstrated particular research creativity; have demonstrated the potential to achieve international recognition in their fields in the next five to ten years; as Chairholders, have the potential to attract, develop and retain excellent trainees, students and future researchers; and be proposing an original, innovative research program of high quality.

 

Applicants who are more than 10 years from having earned their highest degree (and where career breaks exist, such as maternity, parental or extended sick leave, clinical training, etc.) may have their eligibility for a Tier 2 chair assessed through the program’s Tier 2 justification process.

   

Applications should include: 

  

All materials should be submitted to susannah.moore@uhnresearch.ca by September 22, 2023. 

 

For more information about this specific CRC opportunity, please contact margaret.kinyanjui@uhnresearch.ca. 

  

UHN recognizes that scholars have varying career paths and that career interruptions due to personal circumstances can be part of an excellent academic record. Nomination committee members have been instructed to give careful consideration to, and be sensitive to the impact of, career interruptions in their assessments. 

  

UHN is strongly committed to diversity within its community and especially welcomes applications from women, visible minorities, Indigenous persons, persons with a disability and others who may contribute to diversity within our organization. 

  

UHN is a respectful, caring and inclusive workplace. We are committed to championing accessibility and equal opportunity. Requests for accommodation can be made at any stage of the recruitment process, providing the applicant has met the bona fide requirements for the open position. Applicants can make their request for accommodations by contacting edi@uhnresearch.ca. 

  

For further information on the federally endowed Canada Research Chairs Program, open to all nationalities, including eligibility criteria, please consult the Canada Research Chairs website. For more information about the CRC nomination process at the University of Toronto, contact Judith Chadwick, Assistant Vice-President, Research Services, at crc@utoronto.ca. 

  

All applicants to this CRC opportunity are required to self-identify. Self-identification data is important to UHN’s ability to accurately respond to equity targets set by the CRC Program. Because this is a special opportunity for members of the four federally designated equity groups, applicants will be asked separately to provide their consent to use their self-identification information for the purposes of screening and consideration. Please note that this information will be securely accessed only by members of a central selection committee and, for nominees selected, by an Equity Advisor, on a need-to-know basis and will otherwise be kept confidential.